Noticias de investigación sobre quimioterapia
11–20 of 59 artículos
-
ESMO: Eribulin Shows Benefit Across Subgroups (en inglés)
A study suggests that an experimental chemotherapy medicine called eribulin may be a good treatment option for various types of metastatic breast cancer that have stopped responding or failed to respon...
-
ASCO Breast: High Response Rate in Triple-Negative Disease (en inglés)
A small, early study found that 66% of locally advanced, triple-negative breast cancers treated before surgery with a combination of carboplatin (brand name: Paraplatin) and Taxotere (chemical name: do...
-
Cognitive Effects of Breast Cancer Treatment Related to Age (en inglés)
Many women treated with chemotherapy for breast cancer say they have a hard time remembering things, thinking, and concentrating. Doctors call these skills cognitive function.
-
ASE: Early Echo Predicts Heart Damage in Breast CA Therapy (en inglés)
A study suggests that a new way to measure heart damage caused by certain breast cancer treatments may find damage earlier than traditional tests.
-
ASCO: Sea Sponge Drug Saves Lives in Metastatic Breast CA (en inglés)
A study suggests that an experimental chemotherapy medicine called eribulin may be a good treatment option for metastatic breast cancer that has stopped responding or failed to respond to other treatme...
-
Longer Chemo for Breast Cancer More Effective (en inglés)
A study suggests that treating early-stage breast cancer with two common chemotherapy medicines followed by a third (doctors call this a sequential approach) has some advantages compared to giving two ...
-
Modest Antitumor Effects with Bisphosphonate (en inglés)
Zometa (chemical name: zoledronic acid) is a medicine used to strengthen bones in women diagnosed with breast cancer that has spread to the bone. Zometa can reduce bone pain and the risk of broken bone...
-
EBCC: Enzyme's Breast Cancer Role Expands (en inglés)
A study found that breast cancer cells that had high levels of the PARP (polyadenosine diphosphate ADP-ribose polymerase) enzyme were more likely to respond to chemotherapy. These results were presente...
-
EBCC: New Standard Suggested for Metastatic Breast Cancer (en inglés)
The first treatment for HER2-positive, metastatic breast cancer is usually a taxane chemotherapy medicine and the targeted therapy Herceptin (chemical name: trastuzumab).
-
SABCS: Confirmation of Chemo Benefit in Breast Cancer (en inglés)
After surgery to remove early-stage breast cancer, many women are treated with a combination of chemotherapy medicines. If a woman is postmenopausal and the cancer is hormone-receptor-positive, she'll ...
11–20 of 59 artículos
